Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
1秒前
烟花的应助被langwang采纳,获得10
1秒前
许颂完成签到 ,获得积分10
1秒前
aken完成签到,获得积分10
2秒前
852的应助被隐形的如冰采纳,获得10
3秒前
xiaobai完成签到,获得积分10
3秒前
橙汁完成签到,获得积分10
3秒前
nm发布了新的文献求助10
4秒前
柠A完成签到 ,获得积分10
4秒前
Justin发布了新的文献求助10
5秒前
5秒前
林晴发布了新的文献求助10
5秒前
xucc的应助被ssxxx采纳,获得10
6秒前
巴拉巴拉发布了新的文献求助10
6秒前
今后的应助被甜美的友灵采纳,获得10
6秒前
进击的老头关注了科研通微信公众号
6秒前
8秒前
cheng完成签到,获得积分10
8秒前
susu发布了新的文献求助20
9秒前
小黄花525完成签到 ,获得积分10
9秒前
jyliu的应助被酒精采纳,获得10
9秒前
文静的绯完成签到,获得积分10
9秒前
佳jia发布了新的文献求助10
10秒前
MrKeng发布了新的文献求助10
11秒前
Wan完成签到,获得积分10
12秒前
orixero的应助被kcl采纳,获得10
13秒前
lx的应助被CHEN采纳,获得20
13秒前
学术雷锋的应助被勤劳的斑马采纳,获得10
13秒前
顺利幻灵发布了新的文献求助30
13秒前
ll发布了新的文献求助10
13秒前
14秒前
传统的白桃完成签到,获得积分10
14秒前
14秒前
14秒前
科研通AI6.4的应助被12123采纳,获得10
14秒前
15秒前
付银薇完成签到,获得积分10
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Spec 401: Standards for Jet Fuel Facility and Equipment Commissioning and Flushing at Airports, 2026.1 (Original Issue) 1000
Spec 103: Standard for Jet Fuel Quality Control at Airports, Revision 2026.1 1000
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Les Mots du discours 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8089040
求助须知:如何正确求助?哪些是违规求助? 9501963
关于积分的说明 21428530
捐赠科研通 7660514
什么是DOI,文献DOI怎么找? 3404138
关于科研通互助平台的介绍 2532614
邀请新用户注册赠送积分活动 2442696